Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.88 USD | +7.79% | +14.39% | +130.49% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- MGTA Stock
- News Magenta Therapeutics
- Magenta Therapeutics : Reports Additional Positive Data From Phase 2 Trial On MGTA-145, Plerixafor